RE:RE:))))Shroom Doom((((Spor is completely undervalued compared to the big names.I can see us probably having the same earnings as MMED and TRIP with1-10% of the valuation.Nothing makes sense in this and the Cannabis stock segment most investors pile into one or two stocks.Spor will do well as investors pull money away from hyped mega cap names and into real value and growth companies like SPOR.